JP2005500379A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500379A5
JP2005500379A5 JP2003521195A JP2003521195A JP2005500379A5 JP 2005500379 A5 JP2005500379 A5 JP 2005500379A5 JP 2003521195 A JP2003521195 A JP 2003521195A JP 2003521195 A JP2003521195 A JP 2003521195A JP 2005500379 A5 JP2005500379 A5 JP 2005500379A5
Authority
JP
Japan
Prior art keywords
substituted
compound
alkyl
hydrogen
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003521195A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500379A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/026476 external-priority patent/WO2003016267A1/en
Publication of JP2005500379A publication Critical patent/JP2005500379A/ja
Publication of JP2005500379A5 publication Critical patent/JP2005500379A5/ja
Pending legal-status Critical Current

Links

JP2003521195A 2001-08-17 2002-08-19 異脂肪血症および高コレステロール血症を治療するオキシム誘導体 Pending JP2005500379A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31319901P 2001-08-17 2001-08-17
PCT/US2002/026476 WO2003016267A1 (en) 2001-08-17 2002-08-19 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia

Publications (2)

Publication Number Publication Date
JP2005500379A JP2005500379A (ja) 2005-01-06
JP2005500379A5 true JP2005500379A5 (cg-RX-API-DMAC7.html) 2005-11-17

Family

ID=23214760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003521195A Pending JP2005500379A (ja) 2001-08-17 2002-08-19 異脂肪血症および高コレステロール血症を治療するオキシム誘導体

Country Status (4)

Country Link
US (1) US20030083357A1 (cg-RX-API-DMAC7.html)
EP (1) EP1421061A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005500379A (cg-RX-API-DMAC7.html)
WO (1) WO2003016267A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1384825A (zh) * 1999-08-31 2002-12-11 马克西亚药品公司 亚苄基-噻唑烷二酮及其类似物以及它们在治疗糖尿病中的应用
BR0207846A (pt) * 2001-03-07 2005-09-13 Incyte San Diego Inc Derivados heterocìclicos para o tratamento de câncer e outras doenças proliferativas
JP2004523571A (ja) * 2001-03-08 2004-08-05 マキシア・ファーマシューティカルズ・インコーポレイテッド Rxr活性化分子
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
US7196108B2 (en) * 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
BRPI0409501A (pt) * 2003-04-18 2006-04-18 Incyte San Diego Inc compostos isocromanos substituìdos para o tratamento de desordens metabólicas, de cáncer e de outras doenças
US7122700B2 (en) 2004-07-30 2006-10-17 Xerox Corporation Arylamine processes
JP4780372B2 (ja) * 2005-03-02 2011-09-28 独立行政法人産業技術総合研究所 キノキサリンジオン誘導体及びその製造方法並びにその用途
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
WO2016055800A2 (en) * 2014-10-10 2016-04-14 High Force Research Limited Fluorescent synthetic retinoids
WO2022072783A1 (en) 2020-10-02 2022-04-07 Incyte Corporation Bicyclic dione compounds as inhibitors of kras

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051842A (en) * 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de) * 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
US4383529A (en) * 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4931279A (en) * 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
US4713244A (en) * 1985-08-16 1987-12-15 Bausch & Lomb Incorporated Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
DE3874257T2 (de) * 1987-03-11 1993-02-11 Kanegafuchi Chemical Ind Hydroxystyren-derivate.
US5223522A (en) * 1988-03-08 1993-06-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
US5330998A (en) * 1988-03-08 1994-07-19 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
EP0595868B1 (en) * 1991-07-22 1998-11-25 Pfizer Inc. Process for the preparation of (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl]bromobenzene
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
CZ181493A3 (en) * 1992-09-10 1994-03-16 Lilly Co Eli The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease
ES2130597T3 (es) * 1994-02-17 1999-07-01 American Home Prod Derivados de bifenilo sustituido como inhibidores de la fosfodiesterasa.
US5691376A (en) * 1994-02-17 1997-11-25 American Home Products Corporation Substituted biphenyl derivatives
US6127415A (en) * 1996-07-08 2000-10-03 Galderma Research & Development, S.N.C. Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
US6262044B1 (en) * 1998-03-12 2001-07-17 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPASES)
US6462032B1 (en) * 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
CN1384825A (zh) * 1999-08-31 2002-12-11 马克西亚药品公司 亚苄基-噻唑烷二酮及其类似物以及它们在治疗糖尿病中的应用
FR2812876B1 (fr) * 2000-08-08 2002-09-27 Galderma Res & Dev Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
BR0207846A (pt) * 2001-03-07 2005-09-13 Incyte San Diego Inc Derivados heterocìclicos para o tratamento de câncer e outras doenças proliferativas
JP2004523571A (ja) * 2001-03-08 2004-08-05 マキシア・ファーマシューティカルズ・インコーポレイテッド Rxr活性化分子
JP2005513026A (ja) * 2001-11-15 2005-05-12 インサイト サン ディエゴ インコーポレイテッド 高コレステロール血症、異脂肪血症および他の代謝障害;癌、および他の疾患を治療するn−置換複素環
TW200304375A (en) * 2001-12-06 2003-10-01 Maxia Pharmaceuticals Inc 2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
US7196108B2 (en) * 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
US20050014767A1 (en) * 2003-01-29 2005-01-20 Magnus Pfahl Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
BRPI0409501A (pt) * 2003-04-18 2006-04-18 Incyte San Diego Inc compostos isocromanos substituìdos para o tratamento de desordens metabólicas, de cáncer e de outras doenças

Similar Documents

Publication Publication Date Title
TWI376370B (en) Compounds for inflammation and immune-related uses
CN1133627C (zh) N-苄基二氧代噻唑烷基苯甲酰胺衍生物的制造中间体及其制造方法
JP2007523155A5 (cg-RX-API-DMAC7.html)
RU2481330C2 (ru) Азотсодержащее ароматическое гетероциклическое соединение
JP2005539088A5 (cg-RX-API-DMAC7.html)
Mourão et al. Synthesis and biological activity of novel acridinylidene and benzylidene thiazolidinediones
RU2009126745A (ru) Производные сульфонилфенил-2н-{1,2,4}оксадиазол-5-она, способы их получения и их применение в качестве фармацевтических средств
TNSN07361A1 (en) 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
CA2479133A1 (en) 2-4-diaminopyrimidine derivatives
CA2613303A1 (en) An oxime derivative for use as a glucokinase activator
JPWO1994014769A1 (ja) N−置換インドール誘導体
CA2503117A1 (en) Substituted 4-alkoxyoxazol derivatives as ppar agonists
CA2412941A1 (en) Piperidine compounds for use as ccr-3 inhibitors
JP2005511516A5 (cg-RX-API-DMAC7.html)
NO20045497L (no) Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater
JOP20240217A1 (ar) مشتقات الكوينولين كمُعدِّلات للعضو x2 لمستقبل بروتين g مرتبط بـ mas ومنتجات ذات صلة
JP2001525394A5 (cg-RX-API-DMAC7.html)
KR100608416B1 (ko) 2-(n-시아노이미노)티아졸리딘-4-온 유도체
JP2005530705A5 (cg-RX-API-DMAC7.html)
CA2626402A1 (en) Potassium channel inhibitors
JPWO2001036402A1 (ja) 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体
JP2005533064A5 (cg-RX-API-DMAC7.html)
JP2004532267A5 (cg-RX-API-DMAC7.html)
JP2004526721A5 (cg-RX-API-DMAC7.html)
JP2014532656A (ja) 炎症および免疫関連用途のための化合物